House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Orthopaedics

Management of Carpal Tunnel Syndrome

AAOS · 2024 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

AAOS emphasizes clinical diagnosis of adult carpal tunnel syndrome, realistic expectations for nonsurgical treatment, and patient-specific choices around release. It supports CTS-6 instead of routine confirmatory testing, local anaesthesia, nonopioid postoperative analgesia and avoiding routine postoperative immobilization or supervised therapy. Several perioperative decisions remain limited-evidence or consensus options.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Diagnosis and associated disease

  • The CTS-6 clinical tool can diagnose carpal tunnel syndrome without routine ultrasound or nerve-conduction/electromyographic testing. Strong evidence supports this approach; ultrasound or electrodiagnostic testing remains useful when the CTS-6 has low positive predictive value. [1]
  • Do not use MRI or upper-limb neurodynamic testing to diagnose carpal tunnel syndrome; this is a moderate recommendation. The review found poor specificity and no diagnostic advantage over the more appropriate clinical, ultrasound and electrodiagnostic tools. [1]
  • When multiple amyloidosis risk factors are present in a patient undergoing carpal-tunnel release, tenosynovial pathological analysis may be considered. This is consensus guidance; discuss risk factors, preference and possible downstream investigations after a positive sample. [1]
  • The workgroup considers high keyboard use unassociated with carpal tunnel syndrome, but this is a consensus opinion in the absence of reliable evidence. Do not present it as a high-certainty causal finding. [1]

Nonsurgical treatment expectations

  • Corticosteroid injection can give short-term symptom relief in carpal tunnel syndrome, but strong evidence does not support long-term improvement. Discuss local pain or swelling, rare allergy and the small possibility of nerve injury. [1]
  • Do not promise durable benefit from platelet-rich-plasma injection for carpal tunnel syndrome: strong evidence finds no long-term benefit for either leukocyte-rich or leukocyte-poor preparations. Therapeutic ultrasound likewise lacks long-term improvement, although that option has limited strength. [1]
  • For nonsurgical carpal-tunnel symptom treatment, acupressure, insulin injection, heat, magnets, supplements, oral diuretics, oral NSAIDs, oral anticonvulsants and phonophoresis have not demonstrated superiority to placebo or control. This is limited-strength guidance and is distinct from postoperative analgesia. [1]
  • Set realistic long-term expectations for other nonsurgical carpal-tunnel treatments. The limited-strength option finds no improvement in long-term patient-reported outcomes from oral steroids, hyaluronic-acid injection, hydrodissection, kinesiotaping, laser or peloid therapy, perineural or ozone injections, topical or shockwave therapy, exercise, massage, manual therapy or pulsed radiofrequency. [1]
  • The comparisons between nonsurgical carpal-tunnel treatments do not establish a consistently superior option. Interpret this limited-strength finding in light of heterogeneous therapies, controls and follow-up, and discuss each treatment’s time, cost and risks. [1]

Choice and setting of release

  • Mini-open and endoscopic carpal-tunnel release have similar patient-reported outcomes, supported by strong evidence. Any earlier return to work after endoscopy depends on the postoperative plan, occupation and other factors; discuss costs and complications rather than assuming one technique is best for everyone. [1]
  • Local anaesthesia alone can be used for carpal-tunnel release, supported by strong evidence. Discuss patient preference and anxiety as part of shared decision making about an awake procedure. [1]
  • Office-based carpal-tunnel release is a limited-evidence option for appropriately selected patients willing to undergo awake surgery with limited anaesthesia. Limited draping with field sterility is a separate consensus option; the setting recommendation does not remove the requirement for appropriate patient selection. [1]

Perioperative selection and safety

  • Continuation of anticoagulant medication during carpal-tunnel release may be safe, but evidence is limited and decisions depend on the drug, its indication, patient factors and bleeding risk. The directly included studies primarily assessed aspirin; this is not a universal continuation or bridging schedule. [1]
  • Limited evidence suggests that prophylactic perioperative antibiotics are not indicated to prevent infection after carpal-tunnel release. Balance the lack of demonstrated benefit against antibiotic allergy, resistant organisms and C. difficile risk. [1]
  • Avoid routine preoperative laboratory tests, chest radiography or ECG for healthy patients having carpal-tunnel release. This is consensus guidance; use targeted testing in patients with illness when a result could change anaesthetic or perioperative care. [1]

Recovery and analgesia

  • Do not routinely prescribe supervised postoperative therapy after carpal-tunnel release. This moderate recommendation allows individual assessment: some patients may benefit on a case-by-case basis, even though routine functional benefit has not been established. [1]
  • Do not immobilize the wrist with a sling, splint or brace after carpal-tunnel release; this is a moderate recommendation. The reviewed comparisons found no functional or outcome benefit from postoperative splinting. [1]
  • Use NSAIDs and/or paracetamol for pain after carpal-tunnel release, supported by strong evidence, accounting for conditions that may preclude either medicine. The rationale favors nonopioid options to reduce opioid-related harms. [1]
  • If an opioid is being considered for pain after carpal-tunnel release, the workgroup lists tramadol as an option over other opioids. This is a consensus opinion with very-low-quality evidence, not a requirement to prescribe an opioid or a complete safety and dosing protocol. [1]

Limitations and use

  • This adult guideline summary does not supply the CTS-6 scoring algorithm, a universal threshold for surgery, injection doses, an anticoagulant interruption schedule or a return-to-work timetable.
  • The nonoperative-treatment conclusions distinguish short-term symptom relief from long-term benefit. They do not establish that every intervention has the same effect in every patient.
  • The consensus tramadol option does not establish freedom from opioid adverse effects or supersede individual contraindications, interactions and prescribing safeguards.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Management of Carpal Tunnel Syndrome

    Selected recommendation material consulted

Clinical practice guideline

Publication details

Issuing organisation
AAOS
Resource type
Clinical practice guideline · House clinical summary
Source setting
United States

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Diagnosis and associated disease
  • Nonsurgical treatment expectations
  • Choice and setting of release
  • Perioperative selection and safety
  • Recovery and analgesia
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House